Archive for August, 2009

Xenical, Alli Side Effects – Xenical, Alli Liver Failure

Tuesday, August 25th, 2009

The personal injury lawyers of Aylstock, Witkin, Kreis and Overholtz are investigating claims of acute and severe liver failure affecting people using the weight loss drug, orlistat. The investigation follows a health alert by the Food and Drug Administration (FDA) in August 2009, which received 32 reports of liver damage in orlistat users.

Orlistat is sold by prescription under the brand name Xenical, and over-the-counter under the brand name Alli, the first non-prescription weight loss drug to gain FDA approval in 2007. Orlistat serves as a weight loss aid by blocking the absorption of certain fats in the digestive tract, helping patients lose weight with greater ease.

Orlistat began to attract FDA attention following a report of a woman who developed liver failure and required a liver transplant within weeks of taking orlistat. Since 1999, the FDA has received reports of Xenical liver damage and Alli liver injury, with most patients demonstrating jaundice, fatigue and abdominal pain.

If you have developed liver damage and are taking Xenical or Alli, you may be eligible to file a claim against the manufacturers. To learn more about filing a Xenical or Alli lawsuit, contact AWKO Law today at (888) 255-2956.

Students learn Virginia College credits do not transfer to many state universities

Thursday, August 13th, 2009

Students enrolled at Virginia College are finding they cannot transfer their credits to universities to finish their education.

Virginia College students are asking how the school, which bills itself as a “private institution of higher education,” could advertise itself as an accredited educational institution, yet fail to tell them that they type of accreditation Virginia College holds is not recognized as adequate by neighboring universities in most states where VC campuses are located.

Some students are seeking tuition refunds and compensation for the months or years they spent earning college credits that they have now discovered to be useless in pursuing advanced degrees at state universities. They say they could have used that time to pursue credits at less expensive community colleges, where their credits would transfer to state universities without problems.  Among these students, some are asking lawyers whether Virginia College’s claims were false advertising.  Lawyers at Aylstock, Witkin, Kreis & Overholtz have offices near the VC Pensacola campus and are investigating these claims.

The school says its campuses are accredited by the Accrediting Council for Independent Colleges and Schools (ACICS).  However, students say the school’s website and staff never informed them that this type of accreditation is not the kind that public universities in their states require in order to accept transfer credits.

Virginia College has campuses in Alabama, Georgia, Mississippi, South Caronlina, Tennessee, Florida, and Texas, as well as offering online programs.  In most of those states, the public universities do not honor ACICS accreditation when incoming students ask to transfer credits already earned at other schools.  

Educators use the term “regional accreditation” to refer to the more widely recognized, more rigorous accrediting credentials that most major universities hold.  “National accreditation,” which may sound more prestigious, is actually less widely recognized and is often insufficient to qualify incoming transfer credits.  Virginia College’s ACICS accreditation is this second type, which causes problems when students want to transfer into a major, state university. It can also be a problem when moving to many private universities.

Major state universities in Alabama, Florida, Georgia, Mississippi, New York, South Carolina, and Texas require the more respected “regionally accredited” recognition in order to accept incoming transfer credits (see links below).  Other state universities may honor some credits from VC courses, if they recognize “nationally accredited” institutions, but this is less common.

Current or past Virginia College students who have questions about refunds or compensation for tuition and time they invested in course credits that they cannot transfer as needed can contact the lawyers of Aylstock, Witkin, Kreis & Overholtz at 888-255-AWKO (2956).

The lawyers representing Aylstock, Witkin, Kreis & Overholtz are licensed to practice law in eight states (FL, AL, MS, CO, NY, NJ, DC, VA), with associated counsel in all remaining states.

University Policies on Credit Transfers & Accreditation:

University of Alabama – credit transfer policy

University of Mississippi (Ole Miss) – credit transfer policy

University of Georgia – credit transfer policy

University of Texas – credit transfer policy

University of South Carolina – credit transfer policy

University of Tennessee – credit transfer policy

University of West Florida (Pensacola, FL) – credit transfer policy

State University of New York (New Paltz) – credit transfer policy

Students can follow news about this issue on the AWKO Blog or the AWKOLAW Twitter page.

Countrywide Settlement – Countrywide predatory lending practices

Wednesday, August 12th, 2009

Countrywide Loans Settlement Guidelines: Are you Eligible?

In July 2009, the Office of the Attorney General reached a multi-state agreement with Countrywide Financial Corporation and Full Spectrum Lending to provide financial relief for those victimized by Countrywide’s lending practices. The landmark settlement provides approximately $8.68 billion in home loan and foreclosure relief to families throughout the country.

California Attorney General Edmund G. Brown Jr. stated that “Countrywide’s lending practices turned the American dream into a nightmare for tens of thousands of families by putting them into loans they couldn’t understand and ultimately couldn’t afford.” According to Attorney General Brown, “with this settlement, homeowners will receive direct relief from the catastrophic damage caused by Countrywide.”

The settlement follows a lawsuit filed on June 30, 2008, against Countrywide, claiming that the mortgage lender misrepresented loan terms, the potential for loan payment increases and deceived borrowers regarding their ability to sustain loans. The multi-billion dollar settlement is the largest of its kind, drastically surpassing the $484 million settlement in 2002 with Household Finance Corporation.

The Countrywide loan settlement essentially helps subprime and pay-option mortgage borrowers — who are eligible for assistance — evade foreclosure. The types of loans given protection under the settlement are considered to be of the high-risk variety, most commonly associated with default. Attorney General Brown believes that “this loan-modification program provides real relief for borrowers at risk of losing their homes.”

Should you be eligible for participation, there is a deadline for filing a claim form and release to obtain your payment. In accordance with the Florida Attorney General’s Office, Floridians must submit their forms by October 22, 2009. The minimum payment that eligible parties in Florida will receive is $3,019.28.

The skilled and experienced lawyers at Aylstock, Witkin, Kreis and Overholtz are ready to answer your questions about eligibility in the Countrywide loan settlement. Contact AWKO Law today to review your case and determine a course of action.

Remicade side effects linked to Cancer in Children

Tuesday, August 4th, 2009

In August 2009, the Food and Drug Administration (FDA) issued a “black box” warning for several arthritis and inflammatory drugs, including Humira, Remicade, Simponi and Enbrel. The black box warning – the sternest required by the FDA – follows reports linking the arthritis and inflammatory drugs to an increased risk of cancer in children and adolescents.

Prescribed to children to treat rheumatoid arthritis, inflammatory bowel disorder or Crohn’s disease, the drugs neutralize a protein that causes inflammation and tissue damage.

The FDA discovered that children who take the medications for two and a half years or longer are at a heightened risk of developing cancer. Of the several dozen reports of cancer in children taking one of the four medications, more than half developed lymphomas, a type of cancer that affects the immune system.

The drugs are some of the best-selling products of Abbott Laboratories, Amgen Incorporated, Wyeth, and Johnson and Johnson, earning their respective companies billions of dollars in revenue. In 2008 alone, Enbrel sales totaled $3.4 billion.

Parents of children who are taking Humira, Remicade, Simponi or Enbrel and develop cancer may be eligible to file a defective drug case against the drugs’ manufacturers.

The skilled attorneys of Aylstock, Witkin, Kreis and Overholtz are there for victims during these hard times to help them fight against defective drug manufacturers that have cost families financial burdens and emotional distress. Contact AWKO Law today to review your case.

Tumor Necrosis Factor Blockers; Children and Cancer (Remicade, Enbrel, Humira, Cimzia, and Simponi)

Tuesday, August 4th, 2009

The FDA issued a warning today directed to physicians including rheumatologists, gastroenterologists, oncologists, and dermatologists regarding a recent link between Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) and an increased risk of lymphoma and other cancers in children and adolescents. This new safety information is now being added as part of the drugs’ risk profile and has been given the strongest warning possible: the Boxed Warning. The FDA has also identified new safety information related to the occurrence of leukemia and new-onset psoriasis in patients treated with TNF blockers. The current prescribing information or label for TNF blockers does not specifically mention leukemia. TNF blockers are approved for the treatment of one or more of a number of immune system diseases including juvenile idiopathic arthritis (JIA), rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn’s disease, and ankylosing spondylitis.

Read the complete MedWatch 2009 Safety summary, including links to the Information for Healthcare Professionals sheet with recommendations for providers and for patients, and data summaries for the lymphoma, leukemia and psoriasis analyses, at:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm175843.htm

Samantha Burke’s updated statement: Jude Law

Saturday, August 1st, 2009

Attorneys for Samantha Burke have been authorized to release the following statement:

Despite the numerous requests from almost every major media outlet and tabloid magazine, Ms. Burke and her family will not be granting any interviews at this time. This remains a private matter between Jude Law and Samantha Burke. Samantha and her mother would like to be clear that comments attributed to Samantha’s mother in media stories reported within the last twenty-four hours regarding Jude’s contact with Samantha and his involvement were taken out of context. Samantha, her mom, and her family can affirm that Jude has been responsive and supportive throughout the relationship and pregnancy, and know that he will remain so as a father once Baby Sophia is born. Jude and Samantha remain committed to the health and wellbeing of this child, and appreciate your honoring her privacy during this special time.

Samantha Burke provided her statement to local media outlets and can be viewed at www.weartv.com and www.pnj.com.

Samantha Burke also issued a previous statement regarding her pregnancy which can be viewed at: http://www.awkolaw.com/blog/firm-news/samantha-burke-statement-jude-law/

(PDF version of updated statement, 82kb download)